Gilead Sciences

GILD US Health Care Biotechnology
S&P 500 Nasdaq 100
$143.72
-0.75%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Gilead Sciences belong to?
Gilead Sciences operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of GILD?
As of the latest available quote, GILD traded at $143.72. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of GILD?
Gilead Sciences has a price-to-earnings (P/E) ratio of about 21.20. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of GILD?
The market capitalisation of Gilead Sciences is approximately $180.39B.
Is Gilead Sciences profitable?
For its latest reported financial year, Gilead Sciences recorded a net profit margin of about 28.90%.
Does GILD pay a dividend?
Gilead Sciences currently has a dividend yield of about 2.22%.
What is the return on equity (ROE) of GILD?
Gilead Sciences has a return on equity (ROE) of about 71.94%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of GILD?
Over the past 52 weeks, GILD has traded between a low of $108.46 and a high of $157.29.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.